Trifast (TRI) H1 2026 earnings summary

Executive summary

• Delivered improved gross margin (+150 bps) and EBIT margin (+20 bps FX-adjusted) despite challenging macroeconomic conditions, including tariffs, FX volatility, and sector-specific disruptions.

• Strategic focus on margin management, operational efficiency, and portfolio diversification toward smart infrastructure and medical equipment drove performance.

• Underlying earnings expectations for FY2026 remain unchanged, with confidence in achieving >10% EBIT margin medium-term target.

• Maintained strong balance sheet with leverage below 1x and robust liquidity.

Financial highlights

• Gross margin increased to 28.9% (+150 bps YoY), driven by disciplined margin management and operational improvements.

• Underlying EBIT/UOP margin rose to 6.2% from 6.0%; would have been 7.2% FX-adjusted.

• Revenue declined 7% YoY to £105.9m, with notable drops in automotive and white goods, offset by growth in smart infrastructure and medical equipment.

• Underlying profit before tax stable at £4.6m; reported profit before tax increased to £2.5m due to lower one-off items.

• Underlying diluted EPS dropped 19% to 2.38p; interim dividend maintained at 0.60p.

Outlook and guidance

• Full-year guidance for underlying earnings and margin trajectory remains unchanged; focus on self-help actions, working capital, and margin improvement.

• H2 expected to benefit from reduced FX volatility, further pricing and sourcing gains, and cost efficiencies.

• Confident in delivering medium-term targets, including >10% underlying UOP margin.